2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Flexibility in Nucleic Acid Binding Is Central to APOBEC3H Antiviral Activity

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          APOBEC3 proteins are host factors that protect the integrity of the host genome by inhibiting retroelements as well as retroviruses, such as HIV-1. To do this, the APOBEC3H protein has evolved unique interactions with structured RNAs. Here, we studied the importance of these interactions in driving antiviral activity of APOBEC3H. Our results provide a clear picture of how RNA binding drives the ability of APOBEC3H to infiltrate new viruses and prevent synthesis of viral DNA. We also explore how RNA binding by APOBEC3H influences recognition and deamination of viral DNA and describe two possible routes by which APOBEC3H might hypermutate the HIV-1 genome. These results highlight how one protein can sense many nucleic acid species for a variety of antiviral activities.

          ABSTRACT

          APOBEC3 proteins APOBEC3F (A3F), APOBEC3G (A3G), and APOBEC3H (A3H) are host restriction factors that inhibit HIV-1 through DNA cytidine deaminase-dependent and -independent mechanisms and have either one (A3H) or two (A3F and A3G) zinc-binding domains. A3H antiviral activity encompasses multiple molecular functions, all of which depend on recognition of RNA or DNA. A3H crystal structures revealed an unusual interaction with RNA wherein an RNA duplex mediates dimerization of two A3H proteins. In this study, we sought to determine the importance of RNA-binding amino acids in the antiviral and biochemical properties of A3H. We show that the wild-type A3H-RNA interaction is essential for A3H antiviral activity and for two deaminase-independent processes: encapsidation into viral particles and inhibition of reverse transcription. Furthermore, an extensive mutagenesis campaign revealed distinct roles for two groups of amino acids at the RNA binding interface. C-terminal helix residues exclusively bind RNA, and loop 1 residues play a dual role in recognition of DNA substrates and in RNA binding. Weakening the interface between A3H and RNA allows DNA substrates to bind with greater affinity and enhances deamination rates, suggesting that RNA binding must be disrupted to accommodate DNA. Intriguingly, we demonstrate that A3H can deaminate overhanging DNA strands of RNA/DNA heteroduplexes, which are early intermediates during reverse transcription and may represent natural A3H substrates. Overall, we present a mechanistic model of A3H restriction and a step-by-step elucidation of the roles of RNA-binding residues in A3H activity, particle incorporation, inhibition of reverse transcriptase inhibition, and DNA cytidine deamination.

          IMPORTANCE APOBEC3 proteins are host factors that protect the integrity of the host genome by inhibiting retroelements as well as retroviruses, such as HIV-1. To do this, the APOBEC3H protein has evolved unique interactions with structured RNAs. Here, we studied the importance of these interactions in driving antiviral activity of APOBEC3H. Our results provide a clear picture of how RNA binding drives the ability of APOBEC3H to infiltrate new viruses and prevent synthesis of viral DNA. We also explore how RNA binding by APOBEC3H influences recognition and deamination of viral DNA and describe two possible routes by which APOBEC3H might hypermutate the HIV-1 genome. These results highlight how one protein can sense many nucleic acid species for a variety of antiviral activities.

          Related collections

          Author and article information

          Contributors
          Role: Editor
          Journal
          J Virol
          J. Virol
          jvi
          jvi
          JVI
          Journal of Virology
          American Society for Microbiology (1752 N St., N.W., Washington, DC )
          0022-538X
          1098-5514
          2 October 2019
          26 November 2019
          15 December 2019
          : 93
          : 24
          : e01275-19
          Affiliations
          [a ] Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan, USA
          [b ] Life Sciences Institute, University of Michigan, Ann Arbor, Michigan, USA
          [c ] Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA
          [d ] Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA
          Icahn School of Medicine at Mount Sinai
          Author notes
          Address correspondence to Janet L. Smith, janetsmith@ 123456umich.edu .

          Citation Bohn JA, DaSilva J, Kharytonchyk S, Mercedes M, Vosters J, Telesnitsky A, Hatziioannou T, Smith JL. 2019. Flexibility in nucleic acid binding is central to APOBEC3H antiviral activity. J Virol 93:e01275-19. https://doi.org/10.1128/JVI.01275-19.

          Author information
          https://orcid.org/0000-0002-0664-9228
          Article
          PMC6880157 PMC6880157 6880157 01275-19
          10.1128/JVI.01275-19
          6880157
          31578294
          78bce362-adbc-4c4c-a00c-eac7849c5bd5
          Copyright © 2019 American Society for Microbiology.

          All Rights Reserved.

          History
          : 2 August 2019
          : 23 September 2019
          Page count
          Figures: 11, Tables: 3, Equations: 0, References: 63, Pages: 23, Words: 13099
          Funding
          Funded by: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), https://doi.org/10.13039/100000060;
          Award ID: U54 AI150470
          Award Recipient : Award Recipient : Award Recipient :
          Funded by: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), https://doi.org/10.13039/100000060;
          Award ID: R01 AI078788
          Award Recipient :
          Funded by: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), https://doi.org/10.13039/100000060;
          Award ID: F31 AI129697
          Award Recipient :
          Funded by: HHS | NIH | National Institute of General Medical Sciences (NIGMS), https://doi.org/10.13039/100000057;
          Award ID: T32 GM008353
          Award Recipient :
          Categories
          Cellular Response to Infection
          Spotlight
          Custom metadata
          December 2019

          human immunodeficiency virus,heteroduplex,deamination,RNA binding,APOBEC3H

          Comments

          Comment on this article